Posts by: Carolina Henriques

Carolina Henriques

Carolina holds a BSc in Anthropology and a MSc in Urban Studies., and brings her interdisciplinary skills to her writing on a range of different topics in science, research and advocacy news.

October 10, 2017October 10, 2017

Duke Undergrads to Do Medical Research, Including Developing Tool to Spot CF Infections

Cystic Fibrosis, News

Two teams of Duke University undergraduates will be doing health research that is normally the purview of graduate students and professors, including a cystic fibrosis infections project. The 13 students from the Center ... Read more

October 6, 2017October 6, 2017

FDA Opens the Door for People with Asthma to Use Antifungal Therapy Pulmazole

Asthma, Cystic Fibrosis, News

The U.S. Food and Drug Administration has agreed to Pulmatrix’s request to consider making the lung-fungus therapy Pulmazole (PUR1900) available to people with asthma in addition to people with allergic bronchopulmonary aspergillosis, or ... Read more

September 22, 2017September 22, 2017

Veracyte, LCI Aim to Raise Awareness in N.C. About Early Lung Cancer Screening

Lung Cancer, News

In partnership with the Lung Cancer Initiative (LCI), Veracyte has launched an awareness-raising campaign to increase screening for lung cancer among high-risk populations in North Carolina. The campaign, “Screen Together,” was created to ... Read more

September 21, 2017September 21, 2017

IPF World Week 2017: Listening for the Sounds of IPF May Lead to Earlier Diagnosis

Idiopathic Pulmonary Fibrosis, News

Recognizing how difficult it is to diagnose idiopathic pulmonary fibrosis, Boehringer Ingelheim has created a detection system based on sounds coming from the lungs. Because the sounds of people with the disease ... Read more

August 11, 2017August 11, 2017

Pamrevlumab Can Slow Progression of Pulmonary Fibrosis, Phase 2 Clinical Trial Suggests

News

Pulmonary fibrosis patients taking pamrevlumab had less than half the decline in a measure of lung function over 48 weeks than those receiving a placebo, a Phase 2 clinical trial indicates. The ... Read more

August 8, 2017August 8, 2017

Aridis Is Enrolling Patients in Pivotal Trial of Its Antibiotic-resistant Pneumonia Therapy Aerucin

News, Pneumonia

Aridis Pharmaceuticals has begun enrolling patients in what it says will be a pivotal clinical trial of its antibiotic-resistant pneumonia therapy Aerucin. The trial will cover Aerucin’s ability to combine with standard ... Read more

July 26, 2017July 26, 2017

Pulmonary Fibrosis Therapy SM04646 Receives FDA Orphan Drug Designation

Idiopathic Pulmonary Fibrosis, News

The U.S. Food and Drug Administration has granted orphan drug status to SM04646, San Diego-based Samumed‘s treatment for idiopathic pulmonary fibrosis. SM04646, which is delivered in a mist, could be approved as a ... Read more

July 21, 2017July 21, 2017

Maternal Exposure to Environmental Pollution Increases Asthma Risk in Offspring for 3 Generations, Study Finds

Asthma, News

Exposure to environmental pollutants during pregnancy may boost the risk of asthma in offspring for up to three consecutive generations, a study found. The mouse study, “Transgenerational transmission of asthma risk after exposure ... Read more

July 20, 2017July 20, 2017

Samumed Completes Phase 1 Study of Potential IPF Treatment with Positive Results

Idiopathic Pulmonary Fibrosis, News

Samumed has successfully completed a Phase 1 clinical trial in healthy individuals to evaluating a potential therapy — a nebulized inhalation solution called SM04646 — that treats idiopathic pulmonary fibrosis (IPF). The positive ... Read more

July 19, 2017July 19, 2017

Sunovion Divests US Market Rights on Asthma and Allergic Rhinitis Therapies to Focus on COPD

Asthma, COPD, News

Sunovion Pharmaceuticals has entered an agreement with Covis Pharma to divest the U.S. market rights of a series of products based on ciclesonides approved for the treatment of asthma and allergic rhinitis. Ciclesonides are in ... Read more